I apologize for the wide text spread, but after many attempts at getting rid of it and
having lost this post three times already, I'm going with it as is. Since the real value of
this post is as a reference list, I don't think the wide text field will matter much (unless
it causes a site problem).
Please read the attachment first for an understanding of why I have posted this
reference list. I hope it will help you, but please use this information cautiously.
The following is a compilation of resources I've been gathering for the past nine months
on lauric acid/monolaurin/glycerol monolaurate/Lauricidin.
A good place to start is at this webpage, a review in an alternative medicine publication:
"Minimum Inhibitory Concentrations Of Herbal Essential Oils And Monolaurin For Gram-Positive and Gram-Negative Bacteria" by Preuss HG, Echard B, Enig M, Brook I, Elliott TB, April 2005.:
"Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells" by Peterson ML and Schlievert PM, Feb 2006:
"Coconut: In Support of Good Health in the 21st Century" by Mary G. Enid, PhD. Mention of Chlamydia pneumoniae inre artery disease. "...Some of the pathogenic gram-negative bacteria with an appropriate chelator have been reported to be inactivated or killed by lauric acid and monolaurin as well as capric acid and monocaprin (See above, Bergsson et al 1997 and Thormar et al 1999)." So far I haven't been able to get those two full articles, but I'm pursuing them as well as the one listed below on Mpn.
"Effects of monoglycerides on Mycoplasma pneumoniae growth" by RD Fletcher, AC Albers, JN Albertson, JJ Kabara, Journal of the American Oil Chemists' Society , January, 1983 DOI 10.1007/BF02540887 Pages 9-40
http://www.springerlink.com/content/d4t4731271321670/<  (by subscription)
"In Vitro Inactivation of Chlamydia trachomatis by Fatty Acids and Monoglycerides" by Bergsson G, Arnfinnsson J, Karlsson SM, Steingrímsson Ó, Thormar H, Antimicrob Agents Chemother. 1998 September:
"Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori" by Sun CQ, O'Connor CJ, Roberton AM, FEMS Immunol Med Microbiol. 2003 May:
"Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids" by Petschow BW, Batema RP, Ford LL, Antimicrob Agents Chemother. 1996 February.
"In Vitro Susceptibilities of Neisseria gonorrhoeae to Fatty Acids and Monoglycerides" by Bergsson G, Steingrímsson Ó, Thormar H, Antimicrob Agents Chemother. 1999 November:
"In Vitro and In Vivo Evaluations of the Activities of Lauric Acid Monoester Formulations against Staphylococcus aureus" by Rouse MS, Rotger M, Piper KE, Steckelberg JM, Scholz M, Andrews J, Patel R, Aug 2005:
"Equivalence of Lauric Acid and Glycerol Monolaurate as Inhibitors of Signal Transduction in Staphylococcus aureus" by Ruzin A and Novick RP, J Bacteriol. 2000 May:
"Glycerol Monolaurate Inhibits Induction of Vancomycin Resistance in Enterococcus faecalis" by Ruzin A, Novick RP, J Bacteriol. 1998 Jan:
"Glycerol Monolaurate Inhibits Virulence Factor Production in Bacillus anthracis" by Vetter SM, Schlievert PM, Antimicrob Agents Chemother. 2005 April:
"Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction" by Projan SJ, Brown-Skrobot S, Schlievert PM, Vandenesch F, Novick RP, J Bacteriol. 1994 July:
"Effect of glycerol monolaurate on bacterial growth and toxin production" by Schlievert PM, Deringer JR, Kim MH, Projan SJ, Novick RP, Antimicrob Agents Chemother. 1992 March:
"Modulation of immune cell proliferation by glycerol monolaurate" by Witcher KJ, Novick RP, Schlievert PM, Clin Diagn Lab Immunol. 1996 January:
"Influence of selected fatty acids upon plaque formation and caries in the rat" by Williams KA, Schemehorn BR, McDonald JL Jr, Stookey GK, Katz S, Arch Oral Biol. 1982;27(12):1027-31:
"Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides" by Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T, Antimicrob Agents Chemother. 1987 January:
"Effect of antimicrobial factors in human milk on rhinoviruses and milk-borne cytomegalovirus in vitro" by Clarke NM, May JT, J Med Microbiol, 2000 Aug:
Website supportive of lauric acid research, focused on benefit to the HIV/AIDS community:
"Canadian AIDS Treatment Information Exchange...Fact Sheet" on monolaurin:
"Rays of Hope: Managing HIV/AIDS in Africa", a treatment handbook by the Jesuits and Caritas Internationalis. This is a very interesting document.
Go to Appendix 8 on p. 130: http://www.caritas.org/Upload/R/RaysofHope.doc< 
"In Vitro Killing of Candida albicans by Fatty Acids and Monoglycerides" by Bergsson G, Arnfinnsson J, Steingrímsson Ó, Thormar H, Antimicrob Agents Chemother. 2001 Nov:
"Peer reviewed research on coconut oil," a collection of abstracts in re to cholesterol, triglycerides, weight, insulin, etc.:
"A Comprehensive Guide to Managing Autism", by Willis S. Langford, another very interesting document. Dr. X treatments seems to follow this school of thought in treating autism, MS, and other chronic inflammatory diseases. The introduction touches on genetically based underproduction of metallothionein, the factor he thinks underlies and generates all the other factors either directly or indirectly.
Go to p. 83-84 for monolaurin/Lauricidin: http://www.cancertutor.com/Autism/ComprehensiveGuide.doc< 
Lauricidin technical data: http://www.lauricidin.com/tech_data.htm< 
Antimicrobial properties of mother's milk, history of use as an antiseptic:
Clarification and comparison of related substances, more technical data:
Dosage, side effects ("herxing" caution):
A list of the microbes inactivated:
Frequently asked questions: http://www.lauricidin.com/faq.htm< 
Kabara's credentials/resume: http://www.lauricidin.com/kabara.htm< 
Kabara's research, papers, citations: http://www.lauricidin.com/references.htm< 
Cypriane~caregiver/advocate for Steve (SPMSi ) - Cpni  indicated by reactions; Mpn, EBVi , CMV positive; elevated heavy metals; gluten+casein sensitive - Wheldon CAPi  since Aug.06; antivirals; chelation; LDNi ; GF/CF diet.
Cypriane (self)~"Generally Falling Aparti " profile: chronic Cpn infection indicated by reactions and by positive testing, elevated heavy metals, PBSer, borderline diabetic, high cholesterol/triglycerides, HBP, elevated liver enzyme/calcium/iron/RBC/thyroid counts, chronic respiratory infections (before starting the supplementsi <i<  recommended on the CAP), arthritis, DISH, ARD, dry eyes/dry mouth/dry skin, developing cataracts, macular granulation/retinal inflammation, carpal tunnel syndrome, fibrocystic breasts, history of fibroid tumors ending with hysterectomy, fatigue, tinnitus, significantly impaired a.m. balance/cognitive function/coordination. There's probably more, but I can't think of anything else right now...that's enough anyway.
|Lauricidin_notes.doc ||30 KB|